| |
PRODUCT NAME |
ORDER |
 |
Piperazine, 1-cycloheptyl-4-ethyl- (9CI) |
 |
 |
Benzoic acid, 4-amino-2,5-difluoro-3-methoxy- (9CI) |
 |
 |
4-Bromo-2-fluoro-5-methylbenzoic acid |
 |
 |
1,2-Ethanediamine,N-(4-ethylcyclohexyl)-N,N,N-trimethyl-(9CI) |
 |
 |
Piperazine, 1-(4-ethylcyclohexyl)-4-methyl- (9CI) |
 |
 |
Ethanol, 2-[(4-ethylcyclohexyl)propylamino]- (9CI) |
 |
 |
Ethanol, 2,2-[(4-ethylcyclohexyl)imino]bis- (9CI) |
 |
 |
Benzoic acid, 3-acetyl-2,6-dihydroxy-5-methyl- (9CI) |
 |
 |
1,3,4-Thiadiazol-2-amine, N-propyl- |
 |
 |
3-Piperidinecarboxylicacid,1-(3-thienylmethyl)-,hydrazide(9CI) |
 |
 |
3-Piperidinecarboxylicacid,1-(2-furanylmethyl)-,hydrazide(9CI) |
 |
 |
Furan, 4-ethyltetrahydro-2-(4-methoxyphenyl)- (9CI) |
 |
 |
L-Alanine, 3-butenyl ester (9CI) |
 |
 |
Piperazine, 1-ethyl-4-[(5-methyl-2-furanyl)methyl]- (9CI) |
 |
 |
1-(4-(4-((Pyridin-2-yl)methyl)piperazin-1-yl)phenyl)ethanone |
 |
 |
Piperazine, 1-(cyclohexylmethyl)-4-ethyl- (9CI) |
 |
 |
1,7-Dioxaspiro[5.5]undecane-3,4-diol, 9-ethyl-, (3R,4S,6R,9S)- (9CI) |
 |
 |
1,7-Dioxaspiro[5.5]undecane-3,4-diol, 9-ethyl-, (3R,4S,6S,9S)- (9CI) |
 |
 |
5-HEPTYL-2-FURANTHIOL |
 |
 |
2H-Indeno[5,4-d]isoxazole(9CI) |
 |
 |
(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A3,4-A,]DINAPHTHALEN-4-YL)BIS[(1R)-1-PHENYLETHYL]AMINE, DICHLOROMETHANE ADDUCT |
 |
 |
TETRADECYLDIMETHYL(3-TRIMETHOXYSILYLPROPYL)AMMONIUM CHLORIDE; 50% IN METHANOL |
 |
 |
1H-Imidazole-4-sulfonamide,1,2-dimethyl-(9CI) |
 |
 |
2-Pyridineacetonitrile,4-amino-(9CI) |
 |
 |
4-Heptyn-2-one, 3-hydroxy-, (3S)- (9CI) |
 |
 |
5-Hepten-2-one, 3-hydroxy-, (3S,5Z)- (9CI) |
 |
 |
5-Hepten-2-one, 3-hydroxy-, (3S,5E)- (9CI) |
 |
 |
5-Hepten-2-one, 3-hydroxy-6-methyl-, (3S)- (9CI) |
 |
 |
5-Hepten-2-one, 3-hydroxy-, (5Z)- (9CI) |
 |
 |
5-Hepten-2-one, 3-hydroxy- (9CI) |
 |
 |
1-Aza-3-silacyclopentane-5-carboxylicacid,3,3-dimethyl-,(5R)-(9CI) |
 |
 |
NICKEL(II) HYDROXYACETATE |
 |
 |
ALUMINUM 5-CHLORO-8-HYDROXYQUINOLINATE |
 |
 |
4-Thiomorpholinesulfonamide,2-methyl-(7CI,8CI) |
 |
 |
1H-1,4-Diazepin-1-yloxy,hexahydro-2,2,7,7-tetramethyl-5-oxo-(7CI,9CI) |
 |
 |
2-Cyclohexen-1-one,2-methoxy-6-methyl-(9CI) |
 |
 |
Carboplatin |
 |
 |
4H-Inden-1-amine,3-ethoxy-5,6,7,7a-tetrahydro-N,N-dimethyl-(9CI) |
 |
 |
1,3,5-Triazatetracyclo[3.3.1.03,9.07,9]nonane(9CI) |
 |
 |
4(3H)-Pyrimidinone,3-ethyl-6-hydroxy-2-(2-propenylthio)-(9CI) |
 |
 |
4(3H)-Pyrimidinone,3-ethyl-2-(ethylthio)-6-hydroxy-(9CI) |
 |
 |
Benzothiazole, 2-(2-ethoxyethoxy)- (9CI) |
 |
 |
3H-Pyrrolo[1,2-c][1,2,3]triazole,3a,4,5,6-tetrahydro-6-methyl-,(3aR,6R)-rel-(9CI) |
 |
 |
3H-Pyrrolo[1,2-c][1,2,3]triazole,3a,4,5,6-tetrahydro-6-methyl-,(3aR,6S)-rel-(9CI) |
 |
 |
4,7-Methano-1H-benzotriazole,1-butyl-3a,4,5,6,7,7a-hexahydro-,(3aR,4S,7R,7aS)-rel-(9CI) |
 |
 |
3aH-Inden-3a-ol, 1,2,3,4-tetrahydro-4-methyl-, (3aS,4R)- (9CI) |
 |
 |
3aH-Inden-3a-ol, 1,2,3,6-tetrahydro-6-methyl-, (3aS,6S)- (9CI) |
 |
 |
D-erythro-Pentofuranoside, methyl 3-deoxy- (9CI) |
 |
 |
4,6(1H,5H)-Pyrimidinedione,5-ethyldihydro-1-(2-propenyl)-2-thioxo-(9CI) |
 |
 |
Benzothiazole, 2-(2-methoxyethoxy)- (9CI) |
 |